These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9156866)

  • 1. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia.
    Ng PC; Fok TF; So KW; Wong W; Yip PK; Liu K
    Pediatr Surg Int; 1997 Feb; 12(2-3):211-2. PubMed ID: 9156866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia.
    Ng PC; Fok TF; So KW; Wong W; Yip PKF; Liu K
    Pediatr Surg Int; 1997 Mar; 12(2/3):211-2. PubMed ID: 9069241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.
    Ng PC; Brownlee KG; Dear PR
    Arch Dis Child; 1991 Oct; 66(10 Spec No):1164-6. PubMed ID: 1750771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-bowel perforation in very low birth weight neonates treated with high-dose dexamethasone.
    De Laet MH; Dassonville M; Johansson A; Lerminiaux C; Seghers V; Van den Eijnden S; Blum D; Vanderwinden JM
    Eur J Pediatr Surg; 2000 Oct; 10(5):323-7. PubMed ID: 11194544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Stark AR; Carlo WA; Tyson JE; Papile LA; Wright LL; Shankaran S; Donovan EF; Oh W; Bauer CR; Saha S; Poole WK; Stoll BJ;
    N Engl J Med; 2001 Jan; 344(2):95-101. PubMed ID: 11150359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postnatal steroids for the treatment of bronchopulmonary dysplasia: a complex case presentation.
    Forest S
    J Perinat Neonatal Nurs; 2011; 25(3):283-91; quiz 292-3. PubMed ID: 21825919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.
    DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF
    J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants.
    Gordon P; Rutledge J; Sawin R; Thomas S; Woodrum D
    J Perinatol; 1999 Dec; 19(8 Pt 1):573-7. PubMed ID: 10645522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible cardiac changes after dexamethasone treatment for bronchopulmonary dysplasia.
    Riede FT; Schulze E; Vogt L; Schramm D
    Pediatr Cardiol; 2001; 22(4):363-4. PubMed ID: 11455412
    [No Abstract]   [Full Text] [Related]  

  • 10. Which course of dexamethasone?
    Bloomfield FH; Knight DB; Harding JE
    Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F80. PubMed ID: 10325825
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic intestinal perforations in premature infants without evidence of necrotizing enterocolitis.
    Harms K; Lüdtke FE; Lepsien G; Speer CP
    Eur J Pediatr Surg; 1995 Feb; 5(1):30-3. PubMed ID: 7756232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
    Yoder BA; Harrison M; Clark RH
    Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
    Ng PC
    Arch Dis Child; 1993 Mar; 68(3 Spec No):330-6. PubMed ID: 8466274
    [No Abstract]   [Full Text] [Related]  

  • 14. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
    Williams AF
    Arch Dis Child; 1993 Sep; 69(3 Spec No):331. PubMed ID: 8215580
    [No Abstract]   [Full Text] [Related]  

  • 15. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia.
    Ng PC; Wong GW; Lam CW; Lee CH; Fok TF; Wong MY; Wong W; Chan DC
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2429-32. PubMed ID: 9253312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ; Brans YW; Poland RL
    Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
    Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
    Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia.
    Werner JC; Sicard RE; Hansen TW; Solomon E; Cowett RM; Oh W
    J Pediatr; 1992 Feb; 120(2 Pt 1):286-91. PubMed ID: 1735831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroduodenal perforation in preterm babies treated with dexamethasone for bronchopulmonary dysplasia.
    Shimizu T; Yamashiro Y; Yabuta K
    Arch Dis Child; 1992 Apr; 67(4 Spec No):470-1. PubMed ID: 1497731
    [No Abstract]   [Full Text] [Related]  

  • 20. The quality of general movements after treatment with low-dose dexamethasone in preterm infants at risk of bronchopulmonary dysplasia.
    Hitzert MM; Roescher AM; Bos AF
    Neonatology; 2014; 106(3):222-8. PubMed ID: 25012880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.